アルコール使用障害市場：治療タイプ、障害タイプ、流通チャネル別-2025-2030年世界予測

アルコール使用障害市場は、2023年に12億1,000万米ドルと評価され、2024年には12億8,000万米ドルに達すると予測され、CAGR 6.50％で成長し、2030年には18億8,000万米ドルになると予測されています。

アルコール使用障害（AUD）には、苦痛や害につながるさまざまな問題飲酒行動が含まれ、一般に、悪影響があるにもかかわらずアルコール摂取をコントロールできないことが特徴です。AUDに取り組む必要性は、社会的、経済的、健康関連の負担を含む、その公衆衛生上の重大な影響から生じる。その適用範囲は、予防と治療を目的とした医療介入、リハビリテーションプログラム、公衆衛生イニシアチブ、および政策立案に及ぶ。最終用途の範囲には、主にヘルスケアプロバイダー、リハビリテーションセンター、製薬会社、政府機関が含まれます。市場の成長要因としては、メンタルヘルスに対する意識の高まり、治療法の技術的進歩、公衆衛生を推進する政府の取り組みなどが挙げられます。新規医薬品やデジタルヘルスプラットフォームの開発急増は、市場拡大の機会をもたらします。推奨という点では、企業は個別化医療やデジタル治療ツールに向けた動向の高まりを活用し、ユーザーのエンゲージメントと治療効果を高めることができます。

しかし、市場は、AUDにまつわる汚名、高額な治療費、市場浸透の妨げとなる厳しい規制の枠組みなどの限界に直面しています。加えて、発展途上地域における文化の違いや認識不足も成長の課題となっています。技術革新の主な発展分野には、より効果的で依存性の低い薬剤の開発、早期発見と個別化治療計画のためのAI主導型ソリューション、遠隔医療と従来の治療を統合した包括的支援システムなどがあります。この市場の動向から、薬理学的介入と行動学的介入を組み合わせたホリスティック・アプローチへの傾向が明らかになっています。市場の性質はダイナミックであり、メンタルヘルスに対する社会的態度の変化と急速に進化する技術的ランドスケープに後押しされています。統合ケアモデルに焦点を当て、データ分析を活用することで、企業は治療成果を向上させるだけでなく、市場でのプレゼンスを拡大し、アルコール使用障害に効果的に対処することで力強い成長を確保することができます。

市場力学：急速に進化するアルコール使用障害市場の主要市場インサイトを公開

アルコール使用障害市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の薬物乱用事例の増加
  • アルコール依存症を予防、診断、治療するための政府の取り組みと計画
  • アルコール使用の予防と管理のためのデジタルおよび遠隔医療戦略の普及
• 市場抑制要因
  • 性能の限界と効率評価の複雑さ
• 市場機会
  • アルコール使用障害治療薬と診断薬の有効性と効率性を向上させるための調査イニシアティブと進歩
  • アルコール使用管理に役立つ機器、医薬品、製剤の継続的な承認
• 市場の課題
  • アルコール使用障害治療薬および診断薬の戦略開発における複雑さ

ポーターのファイブフォース：アルコール使用障害市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：アルコール使用障害市場における外部からの影響の把握

外部マクロ環境要因は、アルコール使用障害市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析アルコール使用障害市場における競合情勢の把握

アルコール使用障害市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスアルコール使用障害市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、アルコール使用障害市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨アルコール使用障害市場における成功への道筋を描く

アルコール使用障害市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で薬物乱用事件が増加
    • アルコール乱用障害の予防、診断、治療のための政府の取り組みと計画
    • アルコール摂取の予防と管理のためのデジタルおよび遠隔医療戦略の普及
  • 抑制要因
    • パフォーマンスの制限と効率性の評価の複雑さ
  • 機会
    • 治療と診断の有効性と効率性を向上させるための調査イニシアチブと進歩
    • アルコール摂取の管理に役立つ機器、薬剤、製剤の承認が進行中
  • 課題
    • 治療と診断戦略の開発における複雑さ
• 市場セグメンテーション分析
  • 治療タイプ：効果的にコントロールするための行動療法への関心の高まりアルコール使用障害
  • 流通チャネル：回復を支援するために小売薬局による市販薬の利用を増やす
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 アルコール使用障害市場治療の種類別

• 行動療法
• 解毒
• 入院リハビリテーション
• 薬物治療

第7章 アルコール使用障害市場障害の種類別

• アルコール乱用
• アルコール依存症
• 高機能アルコール依存症

第8章 アルコール使用障害市場：流通チャネル別

• 病院薬局
• 小売薬局・ドラッグストア

第9章 南北アメリカのアルコール使用障害市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域のアルコール使用障害市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのアルコール使用障害市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • 研究者らは障害者のアルコール使用障害研究のため340万米ドルの助成金を獲得
  • アフェクト、依存症関連の資金調達が好調で1,600万米ドルを調達
  • Indivior、Opiant Pharmaceuticals, Inc.の買収を完了
• 戦略分析と提言

企業一覧

• Addex Therapeutics
• Adial Pharmaceuticals
• Alkermes
• Astellas Pharma
• Beckley Psytech Limited
• BioCorRx, Inc.
• Bioprojet
• Clairvoyant Therapeutics
• Corcept Therapeutics Inc.
• GlaxoSmithKline PLC
• Indivior Inc.
• Kinnov Therapeutics
• Kinoxis Therapeutics
• Lundbeck
• MediciNova
• Merck & Co. Inc.
• Omeros Corporation
• Otsuka Pharmaceuticals
• Sun Pharmaceutical Industries Limited
• Teva Pharmaceutical Industries Ltd.

LIST OF FIGURES

• FIGURE 1. ALCOHOL USE DISORDER MARKET RESEARCH PROCESS
• FIGURE 2. ALCOHOL USE DISORDER MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ALCOHOL USE DISORDER MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. ALCOHOL USE DISORDER MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ALCOHOL USE DISORDER MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ALCOHOL USE DISORDER MARKET DYNAMICS
• TABLE 7. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY BEHAVIORAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DETOXIFICATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY INPATIENT REHABILITATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY MEDICATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ALCOHOL ABUSE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ALCOHOL DEPENDENCE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY HIGH-FUNCTIONING ALCOHOLISM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 29. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 30. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
• TABLE 31. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 46. CHINA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 47. CHINA ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
• TABLE 48. CHINA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 49. INDIA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 50. INDIA ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
• TABLE 51. INDIA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 101. ITALY ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 102. ITALY ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
• TABLE 103. ITALY ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 113. POLAND ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 114. POLAND ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
• TABLE 115. POLAND ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 116. QATAR ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 117. QATAR ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
• TABLE 118. QATAR ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM ALCOHOL USE DISORDER MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 146. ALCOHOL USE DISORDER MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 147. ALCOHOL USE DISORDER MARKET, FPNV POSITIONING MATRIX, 2023

The Alcohol Use Disorder Market was valued at USD 1.21 billion in 2023, expected to reach USD 1.28 billion in 2024, and is projected to grow at a CAGR of 6.50%, to USD 1.88 billion by 2030.

Alcohol Use Disorder (AUD) encompasses a range of problematic drinking behaviors leading to distress or harm, and it is commonly characterized by an inability to control alcohol intake despite adverse consequences. The necessity for addressing AUD arises from its significant public health impact, which includes social, economic, and health-related burdens. Its application spans medical interventions, rehabilitation programs, public health initiatives, and policy-making aimed at prevention and treatment. The end-use scope primarily involves healthcare providers, rehabilitation centers, pharmaceutical companies, and government agencies. Market growth factors include increasing awareness of mental health, technological advancements in treatment methods, and government initiatives promoting public health. The surge in the development of novel pharmaceuticals and digital health platforms presents opportunities for market expansion. In terms of recommendations, businesses can leverage the growing trend towards personalized medicine and digital therapy tools to enhance user engagement and treatment efficacy.

However, the market faces limitations such as stigmatization associated with AUD, high treatment costs, and stringent regulatory frameworks, which can hinder market penetration. Additionally, cultural variations and lack of awareness in developing regions pose challenges to growth. Key areas for innovation include the development of more effective and less addictive medications, AI-driven solutions for early detection and personalized treatment plans, and comprehensive support systems integrating telehealth with traditional therapy. Insights into this market reveal a trend towards holistic approaches that combine pharmacological and behavioral interventions. The nature of the market is dynamic, driven by shifting societal attitudes towards mental health and rapidly evolving technological landscapes. By focusing on integrated care models and leveraging data analytics, businesses can not only enhance treatment outcomes but also expand their market presence, ensuring robust growth in addressing Alcohol Use Disorder effectively.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Alcohol Use Disorder Market

The Alcohol Use Disorder Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing incidences of substance abuse cases across the world
  • Government initiatives and schemes to prevent, diagnose, and treat alcohol abuse disorder
  • Proliferation of digital and telehealth strategies for preventing and managing alcohol use
• Market Restraints
  • Performance limitations and complexities in evaluating efficiency
• Market Opportunities
  • Research initiatives and advancements to improve the efficacy and efficiency of alcohol use disorder therapeutics and diagnostics
  • Ongoing approvals for devices, drugs, and formulations that help manage alcohol use
• Market Challenges
  • Complexities in developing alcohol use disorder therapeutics and diagnostics strategies

Porter's Five Forces: A Strategic Tool for Navigating the Alcohol Use Disorder Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Alcohol Use Disorder Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Alcohol Use Disorder Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Alcohol Use Disorder Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Alcohol Use Disorder Market

A detailed market share analysis in the Alcohol Use Disorder Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Alcohol Use Disorder Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Alcohol Use Disorder Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Alcohol Use Disorder Market

A strategic analysis of the Alcohol Use Disorder Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Alcohol Use Disorder Market, highlighting leading vendors and their innovative profiles. These include Addex Therapeutics, Adial Pharmaceuticals, Alkermes, Astellas Pharma, Beckley Psytech Limited, BioCorRx, Inc., Bioprojet, Clairvoyant Therapeutics, Corcept Therapeutics Inc., GlaxoSmithKline PLC, Indivior Inc., Kinnov Therapeutics, Kinoxis Therapeutics, Lundbeck, MediciNova, Merck & Co. Inc., Omeros Corporation, Otsuka Pharmaceuticals, Sun Pharmaceutical Industries Limited, and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Alcohol Use Disorder Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Treatment Type, market is studied across Behavioral Therapy, Detoxification, Inpatient Rehabilitation, and Medication.
• Based on Disorder Type, market is studied across Alcohol Abuse, Alcohol Dependence, and High-Functioning Alcoholism.
• Based on Distribution Channel, market is studied across Hospital Pharmacies and Retail Pharmacies & Drug Stores.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing incidences of substance abuse cases across the world
    • 5.1.1.2. Government initiatives and schemes to prevent, diagnose, and treat alcohol abuse disorder
    • 5.1.1.3. Proliferation of digital and telehealth strategies for preventing and managing alcohol use
  • 5.1.2. Restraints
    • 5.1.2.1. Performance limitations and complexities in evaluating efficiency
  • 5.1.3. Opportunities
    • 5.1.3.1. Research initiatives and advancements to improve the efficacy and efficiency of alcohol use disorder therapeutics and diagnostics
    • 5.1.3.2. Ongoing approvals for devices, drugs, and formulations that help manage alcohol use
  • 5.1.4. Challenges
    • 5.1.4.1. Complexities in developing alcohol use disorder therapeutics and diagnostics strategies
• 5.2. Market Segmentation Analysis
  • 5.2.1. Treatment Type: Rising preference for behavioral therapies to effectively control alcohol use disorder
  • 5.2.2. Distribution Channel: Increasing utilization of over-the-counter medications by retail pharmacies to support recovery
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Alcohol Use Disorder Market, by Treatment Type

• 6.1. Introduction
• 6.2. Behavioral Therapy
• 6.3. Detoxification
• 6.4. Inpatient Rehabilitation
• 6.5. Medication

7. Alcohol Use Disorder Market, by Disorder Type

• 7.1. Introduction
• 7.2. Alcohol Abuse
• 7.3. Alcohol Dependence
• 7.4. High-Functioning Alcoholism

8. Alcohol Use Disorder Market, by Distribution Channel

• 8.1. Introduction
• 8.2. Hospital Pharmacies
• 8.3. Retail Pharmacies & Drug Stores

9. Americas Alcohol Use Disorder Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Alcohol Use Disorder Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Alcohol Use Disorder Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Researchers Receive USD 3.4 Million Grant to Study Alcohol Use Disorder Among People with Disabilities
  • 12.3.2. Affect Raises USD 16 Million As Addiction-Related Financings Hold Strong
  • 12.3.3. Indivior Completes Acquisition of Opiant Pharmaceuticals, Inc.
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Addex Therapeutics
• 2. Adial Pharmaceuticals
• 3. Alkermes
• 4. Astellas Pharma
• 5. Beckley Psytech Limited
• 6. BioCorRx, Inc.
• 7. Bioprojet
• 8. Clairvoyant Therapeutics
• 9. Corcept Therapeutics Inc.
• 10. GlaxoSmithKline PLC
• 11. Indivior Inc.
• 12. Kinnov Therapeutics
• 13. Kinoxis Therapeutics
• 14. Lundbeck
• 15. MediciNova
• 16. Merck & Co. Inc.
• 17. Omeros Corporation
• 18. Otsuka Pharmaceuticals
• 19. Sun Pharmaceutical Industries Limited
• 20. Teva Pharmaceutical Industries Ltd.